Clear Harbor Asset Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Clear Harbor Asset Management’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-31,920	Closed	-$37.3K	–	771
2020 Q3	$37.3K	Sell	31,920 -200	-0.6%	-$205	0.01%	426
2020 Q2	$29K	Hold	32,120	–	–	0.01%	265
2020 Q1	$27K	Buy	32,120 +1,425	+5%	+$1.65K	0.01%	262
2019 Q4	$29.5K	Sell	30,695 -4,425	-13%	-$4.85K	0.01%	465
2019 Q3	$36K	Sell	35,120 -32,260	-48%	-$44K	0.01%	255
2019 Q2	$121K	Sell	67,380 -5,000	-7%	-$8.05K	0.02%	235
2019 Q1	$136K	Sell	72,380 -2,500	-3%	-$3.66K	0.03%	230
2018 Q4	$88K	Sell	74,880 -22,750	-23%	-$40.9K	0.02%	221
2018 Q3	$200K	Buy	97,630 +2,000	+2%	+$4.14K	0.04%	223
2018 Q2	$183K	Buy	95,630 +11,000	+13%	+$22.2K	0.03%	224
2018 Q1	$178K	Sell	84,630 -69,170	-45%	-$148K	0.03%	216
2017 Q4	$312K	Buy	+153,800	New	+$319K	0.06%	183

Other funds holding INFI

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Clear Harbor Asset Management's INFI Position: Q4 2020 in Review

Clear Harbor Asset Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2020, closing a stake of 31,920 shares — an estimated $37.3K sold.

Clear Harbor Asset Management first reported a position in INFI in Q4 2017 and held it in 12 quarters. The position peaked at $312K in Q4 2017. 55 funds tracked by Wall St. Rank hold INFI as of Q4 2020.

Clear Harbor Asset Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Clear Harbor Asset Management sold 31,920 Infinity Pharmaceuticals, Inc. shares in Q4 2020, an estimated $37.3K.
Clear Harbor Asset Management first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2017 and held it in 12 quarters.
Clear Harbor Asset Management's Infinity Pharmaceuticals, Inc. position peaked at $312K in Q4 2017.
55 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2020.

Based on Clear Harbor Asset Management's 13F filing for Q4 2020, filed 4 Feb 2021.